Variable | No. | CD68+ macrophages counts in tumor nest | CD68+ macrophages counts in tumor stroma | ||||
---|---|---|---|---|---|---|---|
Low(≤6/HPF) | High(>6/HPF) | P | Low(≤8/HPF) | High(>8/HPF) | P | ||
Sex | Â | Â | Â | 0.176 | Â | Â | 0.060 |
 Male | 74 | 34 | 40 |  | 30 | 44 |  |
 Female | 53 | 18 | 35 |  | 13 | 40 |  |
Age (years) | Â | Â | Â | 0.773 | Â | Â | 0.927 |
 ≤50 | 26 | 10 | 16 |  | 9 | 17 |  |
 >50 | 101 | 42 | 59 |  | 34 | 67 |  |
Tumor location | Â | Â | Â | 0.034 | Â | Â | 0.346 |
 Tongue | 52 | 29 | 23 |  | 20 | 32 |  |
 Gingiva | 26 | 7 | 19 |  | 8 | 18 |  |
 Buccal mucosa | 31 | 8 | 23 |  | 6 | 25 |  |
 Lip | 4 | 3 | 1 |  | 2 | 2 |  |
 Floor of the mouth | 2 | 1 | 1 |  | 1 | 1 |  |
 Others | 12 | 4 | 8 |  | 6 | 6 |  |
Tumor size | Â | Â | Â | 0.665 | Â | Â | 0.369 |
 T1 | 21 | 9 | 12 |  | 7 | 14 |  |
 T2 | 68 | 28 | 40 |  | 21 | 47 |  |
 T3 | 26 | 12 | 14 |  | 8 | 18 |  |
 T4 | 12 | 3 | 9 |  | 7 | 5 |  |
Lymph node metastasis | Â | Â | Â | 0.850 | Â | Â | 0.321 |
 N0 | 72 | 30 | 42 |  | 27 | 45 |  |
 N (+) | 55 | 22 | 33 |  | 16 | 39 |  |
Metastasis | Â | Â | Â | 0.793 | Â | Â | 0.627 |
 M0 | 125 | 51 | 74 |  | 42 | 83 |  |
 M (+) | 2 | 1 | 1 |  | 1 | 1 |  |
Clinical stage | Â | Â | Â | 0.262 | Â | Â | 0.699 |
 I | 12 | 5 | 7 |  | 4 | 8 |  |
 II | 42 | 19 | 23 |  | 17 | 25 |  |
 III | 34 | 16 | 18 |  | 8 | 26 |  |
 IV | 39 | 12 | 27 |  | 14 | 25 |  |
Pathological grade | Â | Â | Â | 0.135 | Â | Â | 0.296 |
 I | 76 | 34 | 42 |  | 24 | 52 |  |
 II | 42 | 18 | 24 |  | 13 | 29 |  |
 III | 9 | 0 | 9 |  | 6 | 3 |  |
Recurrence | Â | Â | Â | 0.111 | Â | Â | 0.259 |
 No | 83 | 39 | 44 |  | 25 | 58 |  |
 Yes | 42 | 13 | 29 |  | 18 | 24 |  |
 Lost | 2 | 0 | 2 |  | 0 | 2 |  |
Follow-up | Â | Â | Â | 0.005 | Â | Â | 0.218 |
 Live | 91 | 45 | 46 |  | 27 | 64 |  |
 Dead | 33 | 7 | 26 |  | 15 | 18 |  |
 Lost | 3 | 0 | 3 |  | 1 | 2 |  |